Advancing Care and Pathogenesis of Intractable Adrenal diseases in Japan

Advancing Care and Pathogenesis of Intractable Adrenal diseases in Japan - Advancing Care and Pathogenesis of Intractable Adrenal diseases in Japan

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021437

Enrollment

2000

Registered

2016-03-11

Start date

2016-09-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pheochromocytoma, Cushing syndrome, subclinical Cushing syndrome, ACTH Independent Macronodular Adrenal Hyperplasia (AIMAH), Adrenocortical cancer, nonfunctioning adrenal tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed as pheochromocytoma and paraganglioma, Cushing syndrome, subclinical Cushing syndrome, Primary bilateral macronodular adrenal hyperplasia (PBMAH), adrenocortical cancer (ACC), and nonfunctioning adrenal tumor in department of diabetes, endocrinology and metabolism, national center for global health and medicine and collaborated institutes from Jan, 2006.

Exclusion criteria

Exclusion criteria: Patients who were considered as unsuitable for this study.

Design outcomes

Primary

Measure	Time frame
Relationship between clinical findings (baseline characteristics, hormonal data, imaging findings or treatments) and clinical course or prognosis.	—

Countries

Japan

Contacts

Public ContactAkiyo Tanabe

National Center for Global Health and Medicine, Japan Institute for Health Security Department of Diabetes, Endocrinology and Metabolism

tanabe.a@jihs.go.jp03-3202-7181

Outcome results